Methods
The study received local ethical approval and all patients gave written informed consent. A consecutive series of patients referred to clinical CMR exam were included. The amyloidosis group included patients diagnosed of systemic AL amyloidosis with definite clinical cardiac involvement. The control group included other patients with neither clinical evidence for infiltrative cardiomyopathy nor late gadolinium enhancement (LGE) found in CMR. All the patients underwent a standardized bolus contrast-enhanced CMR (3.0T) imaging composed of native, 5 minutes (min) and 15-20 min post-contrast T1 mapping using a Modified Look Lockers Inversion (MOLLI) recovery sequence in identical imaging locations, including a long axis 4-chamber (4ch) slice and a middle short axis 2-chamber (2ch) slice. ECV analyses using the 5 min (ECV1) and 15-20 min (ECV2) post-contrast T1 mapping images were accomplished semi-automatically by a dedicated software. Native T1, ECV1 and ECV2 value of identical region of interest in interventricular septum were measured and compared between amyloidosis group and control group by MannWhitney test. Paired ECV1 and ECV2 values in same region were compared by Wilcoxon test.
Results
The amyloidosis group recruited 25 patients (mean age 54 ± 10 years, 13 men).10(40%) of them had an endomyocardium biopsy, all of which obtained a histological proof of cardiac amyloidosis by Congo red histology. The control group included 17 patients (mean age 41 ± 12 years, 12 men). Myocardial native T1, ECV1 and ECV2 all significantly elevated in amyloidosis group compared to control group both in 4ch slice ( LGE, native T1 mapping, ECV1(calculated by native and 5 min post-contrast T1 mapping) and ECV2 map(calculated by native and 15-20 min post-contrast T1 mapping) images in identical short axis 2 chamber slice of a endomyocardial biopsy proved cardiac amyloidosis patients. Interventricular septum late enhancement was uncertain in LGE image, but region of interest measurements showed significantly elevated native T1(1466 ms), ECV1(0.55) and ECV2(0.55) of myocardium.
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